Dimension Therapeutics, Inc
DMTX
DMTX was delisted on the 6th of November, 2017.
47 hedge funds and large institutions have $32.7M invested in Dimension Therapeutics, Inc in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 7 closing their positions.
38% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 13
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
15% less funds holding
Funds holding: 55 → 47 (-8)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
64% less capital invested
Capital invested by funds: $90M → $32.7M (-$57.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.45M |
| 2 |
TSS
Two Sigma Securities
New York
|
+$164K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
+$101K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$72.1K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$68.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$4.82M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$4.04M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$266K |
| 4 |
JP Morgan Chase
New York
|
-$233K |
| 5 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$131K |
DMTX Hedge Fund Activity: Q1 2017 in Review
47 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Dimension Therapeutics, Inc (DMTX) for Q1 2017, worth a combined $32.7M — down 64% from $90M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of DMTX and 4 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 18 added.
The largest buyer was BlackRock, adding an estimated $1.45M. The largest seller was Janus Henderson Investors US, exiting entirely with an estimated $4.82M sold.
- 47 institutional investors held Dimension Therapeutics, Inc (DMTX) as of Q1 2017, down from 55 in Q4 2016.
- Funds reported $32.7M of Dimension Therapeutics, Inc stock for Q1 2017, down 64% quarter-over-quarter.
- 4 funds opened new Dimension Therapeutics, Inc positions in Q1 2017 and 7 closed out, a net change of -3 holders.
- The largest Dimension Therapeutics, Inc buyer in Q1 2017 was BlackRock, an estimated $1.45M added.
- The largest Dimension Therapeutics, Inc seller in Q1 2017 was Janus Henderson Investors US, an estimated $4.82M sold.
Based on aggregated 13F filings for Q1 2017.